Skip to main content
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1994 Oct;102(10):858–861. doi: 10.1289/ehp.94102858

Nitrite inhalants: history, epidemiology, and possible links to AIDS.

H W Haverkos 1, A N Kopstein 1, H Wilson 1, P Drotman 1
PMCID: PMC1567358  PMID: 9644194

Abstract

Nitrite inhalants have been commonly abused substances in the United States. Nitrite inhalants and AIDS was a popular topic in the early 1980s, when the cause of AIDS was not known. With the discovery of HIV, concern about nitrite use in the USA waned. However, nitrite inhalant use is associated with behavioral relapse and HIV transmission among gay men, with decreased lymphocyte counts and natural killer cell activity in a few laboratory studies, and it remains a candidate cofactor in the pathogenesis of AIDS-related Kaposi's sarcoma. Discouraging nitrite use continues to be a worthwhile public health goal.

Full text

PDF
858

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Archibald C. P., Schechter M. T., Craib K. J., Le T. N., Douglas B., Willoughby B., O'Shaughnessy M. Risk factors for Kaposi's sarcoma in the Vancouver Lymphadenopathy-AIDS Study. J Acquir Immune Defic Syndr. 1990;3 (Suppl 1):S18–S23. [PubMed] [Google Scholar]
  2. Archibald C. P., Schechter M. T., Le T. N., Craib K. J., Montaner J. S., O'Shaughnessy M. V. Evidence for a sexually transmitted cofactor for AIDS-related Kaposi's sarcoma in a cohort of homosexual men. Epidemiology. 1992 May;3(3):203–209. doi: 10.1097/00001648-199205000-00004. [DOI] [PubMed] [Google Scholar]
  3. Armenian H. K., Hoover D. R., Rubb S., Metz S., Kaslow R., Visscher B., Chmiel J., Kingsley L., Saah A. Composite risk score for Kaposi's sarcoma based on a case-control and longitudinal study in the Multicenter AIDS Cohort Study (MACS) population. Am J Epidemiol. 1993 Aug 15;138(4):256–265. doi: 10.1093/oxfordjournals.aje.a116854. [DOI] [PubMed] [Google Scholar]
  4. Barré-Sinoussi F., Chermann J. C., Rey F., Nugeyre M. T., Chamaret S., Gruest J., Dauguet C., Axler-Blin C., Vézinet-Brun F., Rouzioux C. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science. 1983 May 20;220(4599):868–871. doi: 10.1126/science.6189183. [DOI] [PubMed] [Google Scholar]
  5. Beral V., Peterman T. A., Berkelman R. L., Jaffe H. W. Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection? Lancet. 1990 Jan 20;335(8682):123–128. doi: 10.1016/0140-6736(90)90001-l. [DOI] [PubMed] [Google Scholar]
  6. Calzavara L. M., Coates R. A., Raboud J. M., Farewell V. T., Read S. E., Shephered F. A., Fanning M. M., MacFadden D. Ongoing high-risk sexual behaviors in relation recreational drug use in sexual encounters. Analysis of 5 years of data from the Toronto Sexual Contact Study. Ann Epidemiol. 1993 May;3(3):272–280. doi: 10.1016/1047-2797(93)90030-8. [DOI] [PubMed] [Google Scholar]
  7. Dax E. M., Adler W. H., Nagel J. E., Lange W. R., Jaffe J. H. Amyl nitrite alters human in vitro immune function. Immunopharmacol Immunotoxicol. 1991;13(4):577–587. doi: 10.3109/08923979109019724. [DOI] [PubMed] [Google Scholar]
  8. Des Jarlais D. C., Stoneburner R., Thomas P., Friedman S. R. Declines in proportion of Kaposi's sarcoma among cases of AIDS in multiple risk groups in New York City. Lancet. 1987 Oct 31;2(8566):1024–1025. doi: 10.1016/s0140-6736(87)92586-4. [DOI] [PubMed] [Google Scholar]
  9. Drew W. L., Mills J., Hauer L. B., Miner R. C., Rutherford G. W. Declining prevalence of Kaposi's sarcoma in homosexual AIDS patients paralleled by fall in cytomegalovirus transmission. Lancet. 1988 Jan 2;1(8575-6):66–66. doi: 10.1016/s0140-6736(88)91053-7. [DOI] [PubMed] [Google Scholar]
  10. Durack D. T. Opportunistic infections and Kaposi's sarcoma in homosexual men. N Engl J Med. 1981 Dec 10;305(24):1465–1467. doi: 10.1056/NEJM198112103052408. [DOI] [PubMed] [Google Scholar]
  11. Ebbesen P., Melbye M., Biggar R. J. Sex habits, recent disease, and drug use in two groups of Danish male homosexuals. Arch Sex Behav. 1984 Aug;13(4):291–300. doi: 10.1007/BF01541902. [DOI] [PubMed] [Google Scholar]
  12. Gaworski C. L., Aranyi C., Hall A., 3rd, Levine B. S., Jackson C. D., Abdo K. M. Prechronic inhalation toxicity studies of isobutyl nitrite. Fundam Appl Toxicol. 1992 Aug;19(2):169–175. doi: 10.1016/0272-0590(92)90148-b. [DOI] [PubMed] [Google Scholar]
  13. Giraldo G., Beth E., Haguenau F. Herpes-type virus particles in tissue culture of Kaposi's sarcoma from different geographic regions. J Natl Cancer Inst. 1972 Dec;49(6):1509–1526. doi: 10.1093/jnci/49.6.1509. [DOI] [PubMed] [Google Scholar]
  14. Giraldo G., Beth E., Huang E. S. Kaposi's sarcoma and its relationship to cytomegalovirus (CMNV). III. CMV DNA and CMV early antigens in Kaposi's sarcoma. Int J Cancer. 1980 Jul 15;26(1):23–29. doi: 10.1002/ijc.2910260105. [DOI] [PubMed] [Google Scholar]
  15. Goedert J. J., Neuland C. Y., Wallen W. C., Greene M. H., Mann D. L., Murray C., Strong D. M., Fraumeni J. F., Jr, Blattner W. A. Amyl nitrite may alter T lymphocytes in homosexual men. Lancet. 1982 Feb 20;1(8269):412–416. doi: 10.1016/s0140-6736(82)91617-8. [DOI] [PubMed] [Google Scholar]
  16. Haverkos H. W., Drotman D. P., Morgan W. M. Kaposi's sarcoma in patients with AIDS: sex, transmission mode, and race. Biomed Pharmacother. 1990;44(9):461–466. doi: 10.1016/0753-3322(90)90206-o. [DOI] [PubMed] [Google Scholar]
  17. Haverkos H. W., Drotman D. P. Prevalence of Kaposi's sarcoma among patients with AIDS. N Engl J Med. 1985 Jun 6;312(23):1518–1518. [PubMed] [Google Scholar]
  18. Haverkos H. W. Factors associated with the pathogenesis of AIDS. J Infect Dis. 1987 Jul;156(1):251–257. doi: 10.1093/infdis/156.1.251. [DOI] [PubMed] [Google Scholar]
  19. Haverkos H. W., Friedman-Kien A. E., Drotman D. P., Morgan W. M. The changing incidence of Kaposi's sarcoma among patients with AIDS. J Am Acad Dermatol. 1990 Jun;22(6 Pt 2):1250–1253. doi: 10.1016/0190-9622(90)70170-m. [DOI] [PubMed] [Google Scholar]
  20. Haverkos H. W., Pinsky P. F., Drotman D. P., Bregman D. J. Disease manifestation among homosexual men with acquired immunodeficiency syndrome: a possible role of nitrites in Kaposi's sarcoma. Sex Transm Dis. 1985 Oct-Dec;12(4):203–208. doi: 10.1097/00007435-198510000-00007. [DOI] [PubMed] [Google Scholar]
  21. Hersh E. M., Reuben J. M., Bogerd H., Rosenblum M., Bielski M., Mansell P. W., Rios A., Newell G. R., Sonnenfeld G. Effect of the recreational agent isobutyl nitrite on human peripheral blood leukocytes and on in vitro interferon production. Cancer Res. 1983 Mar;43(3):1365–1371. [PubMed] [Google Scholar]
  22. Jaffe H. W., Choi K., Thomas P. A., Haverkos H. W., Auerbach D. M., Guinan M. E., Rogers M. F., Spira T. J., Darrow W. W., Kramer M. A. National case-control study of Kaposi's sarcoma and Pneumocystis carinii pneumonia in homosexual men: Part 1. Epidemiologic results. Ann Intern Med. 1983 Aug;99(2):145–151. doi: 10.7326/0003-4819-99-2-145. [DOI] [PubMed] [Google Scholar]
  23. Jørgensen K. A., Lawesson S. O. Amyl nitrite and Kaposi's sarcoma in homosexual men. N Engl J Med. 1982 Sep 30;307(14):893–894. doi: 10.1056/NEJM198209303071414. [DOI] [PubMed] [Google Scholar]
  24. Lewis D. M., Koller W. A., Lynch D. W., Spira T. J. Subchronic inhalation toxicity of isobutyl nitrite in BALB/c mice. II. Immunotoxicity studies. J Toxicol Environ Health. 1985;15(6):835–846. doi: 10.1080/15287398509530709. [DOI] [PubMed] [Google Scholar]
  25. Lo S. C. Isolation and identification of a novel virus from patients with AIDS. Am J Trop Med Hyg. 1986 Jul;35(4):675–676. doi: 10.4269/ajtmh.1986.35.675. [DOI] [PubMed] [Google Scholar]
  26. Lotzová E., Savary C. A., Hersh E. M., Khan A. A., Rosenblum M. Depression of murine natural killer cell cytotoxicity by isobutyl nitrite. Cancer Immunol Immunother. 1984;17(2):130–134. doi: 10.1007/BF00200049. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Lynch D. W., Moorman W. J., Burg J. R., Phipps F. C., Lewis T. R., Khan A., Lewis D. M., Chandler F. W., Kimbrough R. D., Spira T. J. Subchronic inhalation toxicity of isobutyl nitrite in BALB/c mice. I. Systemic toxicity. J Toxicol Environ Health. 1985;15(6):823–833. doi: 10.1080/15287398509530708. [DOI] [PubMed] [Google Scholar]
  28. Marmor M., Friedman-Kien A. E., Laubenstein L., Byrum R. D., William D. C., D'onofrio S., Dubin N. Risk factors for Kaposi's sarcoma in homosexual men. Lancet. 1982 May 15;1(8281):1083–1087. doi: 10.1016/s0140-6736(82)92275-9. [DOI] [PubMed] [Google Scholar]
  29. Mathur-Wagh U., Mildvan D., Senie R. T. Follow-up at 41/2 years on homosexual men with generalized lymphadenopathy. N Engl J Med. 1985 Dec 12;313(24):1542–1543. doi: 10.1056/NEJM198512123132412. [DOI] [PubMed] [Google Scholar]
  30. Mirvish S. S., Haverkos H. W. Butyl nitrite in the induction of Kaposi's sarcoma in AIDS. N Engl J Med. 1987 Dec 17;317(25):1603–1603. doi: 10.1056/NEJM198712173172513. [DOI] [PubMed] [Google Scholar]
  31. Mirvish S. S., Williamson J., Babcook D., Chen S. C. Mutagenicity of iso-butyl nitrite vapor in the Ames test and some relevant chemical properties, including the reaction of iso-butyl nitrite with phosphate. Environ Mol Mutagen. 1993;21(3):247–252. doi: 10.1002/em.2850210307. [DOI] [PubMed] [Google Scholar]
  32. Newell G. R., Mansell P. W., Spitz M. R., Reuben J. M., Hersh E. M. Volatile nitrites. Use and adverse effects related to the current epidemic of the acquired immune deficiency syndrome. Am J Med. 1985 May;78(5):811–816. doi: 10.1016/0002-9343(85)90288-8. [DOI] [PubMed] [Google Scholar]
  33. Ortiz J. S., Rivera V. L. Altered T-cell helper/suppressor ratio in mice chronically exposed to amyl nitrite. NIDA Res Monogr. 1988;83:59–74. [PubMed] [Google Scholar]
  34. Ostrow D. G., VanRaden M. J., Fox R., Kingsley L. A., Dudley J., Kaslow R. A. Recreational drug use and sexual behavior change in a cohort of homosexual men. The Multicenter AIDS Cohort Study (MACS). AIDS. 1990 Aug;4(8):759–765. doi: 10.1097/00002030-199008000-00007. [DOI] [PubMed] [Google Scholar]
  35. Pearlman J. T., Adams G. L. Amyl nitrite inhalation fad. JAMA. 1970 Apr 6;212(1):160–160. [PubMed] [Google Scholar]
  36. Penkower L., Dew M. A., Kingsley L., Becker J. T., Satz P., Schaerf F. W., Sheridan K. Behavioral, health and psychosocial factors and risk for HIV infection among sexually active homosexual men: the Multicenter AIDS Cohort Study. Am J Public Health. 1991 Feb;81(2):194–196. doi: 10.2105/ajph.81.2.194. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Peterman T. A., Jaffe H. W., Feorino P. M., Getchell J. P., Warfield D. T., Haverkos H. W., Stoneburner R. L., Curran J. W. Transfusion-associated acquired immunodeficiency syndrome in the United States. JAMA. 1985 Nov 22;254(20):2913–2917. [PubMed] [Google Scholar]
  38. Popovic M., Sarngadharan M. G., Read E., Gallo R. C. Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science. 1984 May 4;224(4648):497–500. doi: 10.1126/science.6200935. [DOI] [PubMed] [Google Scholar]
  39. Ross M. W., Drew P. A. Effects of nitrite use on lymphocyte mitogenesis in homosexual men. Int J STD AIDS. 1991 Mar-Apr;2(2):133–135. doi: 10.1177/095646249100200212. [DOI] [PubMed] [Google Scholar]
  40. Schwartz R. H., Peary P. Abuse of isobutyl nitrite inhalation (Rush) by adolescents. Clin Pediatr (Phila) 1986 Jun;25(6):308–310. doi: 10.1177/000992288602500605. [DOI] [PubMed] [Google Scholar]
  41. Sigell L. T., Kapp F. T., Fusaro G. A., Nelson E. D., Falck R. S. Popping and snorting volatile nitrites: a current fad for getting high. Am J Psychiatry. 1978 Oct;135(10):1216–1218. doi: 10.1176/ajp.135.10.1216. [DOI] [PubMed] [Google Scholar]
  42. Soderberg L. S., Barnett J. B. Exposure to inhaled isobutyl nitrite reduces T cell blastogenesis and antibody responsiveness. Fundam Appl Toxicol. 1991 Nov;17(4):821–824. doi: 10.1016/0272-0590(91)90188-a. [DOI] [PubMed] [Google Scholar]
  43. Stall R., McKusick L., Wiley J., Coates T. J., Ostrow D. G. Alcohol and drug use during sexual activity and compliance with safe sex guidelines for AIDS: the AIDS Behavioral Research Project. Health Educ Q. 1986 Winter;13(4):359–371. doi: 10.1177/109019818601300407. [DOI] [PubMed] [Google Scholar]
  44. Ward J. W., Bush T. J., Perkins H. A., Lieb L. E., Allen J. R., Goldfinger D., Samson S. M., Pepkowitz S. H., Fernando L. P., Holland P. V. The natural history of transfusion-associated infection with human immunodeficiency virus. Factors influencing the rate of progression to disease. N Engl J Med. 1989 Oct 5;321(14):947–952. doi: 10.1056/NEJM198910053211406. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES